Vid Desai FDA’s Chief Information Officer | Official Website
Vid Desai FDA’s Chief Information Officer | Official Website
This is an increase over the number of companies cited in the previous month.
The citations in the county include:
- The responsibilities and procedures applicable to the quality control unit are not in writing and fully followed.
- Drug product component testing is deficient in that at least one specific test to verify the identity of each component is not performed.
- Your firm failed to establish written procedures for production and process controls designed to assure that the drug products have the identity, strength, purity, and quality that they are purported or represented to possess.
The company cited was involved in the Drugs sector.
The company cited had to take regulatory and/or administrative actions.
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
According to its website, the FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality.
| Company Name | Area of Business | Inspection Date | Issue Cited |
|---|---|---|---|
| Nature'S Fusions, LLC | Drugs | 01/21/2025 | Procedures not in writing, fully followed |
| Nature'S Fusions, LLC | Drugs | 01/21/2025 | Component identity verification |
| Nature'S Fusions, LLC | Drugs | 01/21/2025 | Absence of Written Procedures |
| Nature'S Fusions, LLC | Drugs | 01/21/2025 | Expiration date lacking |
| Nature'S Fusions, LLC | Drugs | 01/21/2025 | Storage under appropriate conditions |
| Nature'S Fusions, LLC | Drugs | 01/21/2025 | Microbiological testing |
| Nature'S Fusions, LLC | Drugs | 01/21/2025 | Items to cover on annual reviews |
Alerts Sign-up